Allianz Asset Management
AVNS

Allianz Asset Management’s Avanos Medical AVNS Stock Holding History

Allianz Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.29M Buy
373,397
+107,825
+41% +$2.52M 0.01% 1108
2026
Q1 		$3.72M Buy
265,572
+124,203
+88% +$1.67M ﹤0.01% 1300
2025
Q4 		$1.59M Buy
141,369
+81,834
+137% +$936K ﹤0.01% 1615
2025
Q3 		$688K Buy
59,535
+17,802
+43% +$208K ﹤0.01% 1785
2025
Q2 		$511K Buy
+41,733
New +$525K ﹤0.01% 1827
2024
Q4 		– Sell
-13,300
Closed -$320K – 2210
2024
Q3 		$320K Sell
13,300
-17,400
-57% -$398K ﹤0.01% 1975
2024
Q2 		$612K Hold
30,700
– – ﹤0.01% 1769
2024
Q1 		$611K Hold
30,700
– – ﹤0.01% 1558
2023
Q4 		$689K Hold
30,700
– – ﹤0.01% 1746
2023
Q3 		$621K Hold
30,700
– – ﹤0.01% 1854
2023
Q2 		$785K Buy
+30,700
New +$809K ﹤0.01% 1616
2019
Q1 		– Sell
-143,608
Closed -$6.43M – 2666
2018
Q4 		$6.43M Sell
143,608
-154,111
-52% -$8.07M 0.01% 1309
2018
Q3 		$20.4M Sell
297,719
-77,966
-21% -$5.02M 0.02% 883
2018
Q2 		$21.5M Buy
375,685
+184,235
+96% +$9.74M 0.02% 839
2018
Q1 		$8.82M Buy
191,450
+33,242
+21% +$1.58M 0.01% 1306
2017
Q4 		$7.31M Buy
158,208
+104,386
+194% +$4.8M 0.01% 1471
2017
Q3 		$2.42M Buy
53,822
+1,360
+3% +$58K ﹤0.01% 1938
2017
Q2 		$2.06M Sell
52,462
-1,805
-3% -$68.2K ﹤0.01% 1972
2017
Q1 		$2.07M Buy
54,267
+13,825
+34% +$539K ﹤0.01% 1982
2016
Q4 		$1.5M Buy
40,442
+20,400
+102% +$729K ﹤0.01% 2074
2016
Q3 		$694K Buy
+20,042
New +$702K ﹤0.01% 2303
2015
Q4 		– Sell
-11,897
Closed -$338K – 2442
2015
Q3 		$338K Sell
11,897
-11,042
-48% -$385K ﹤0.01% 2167
2015
Q2 		$929K Buy
22,939
+1,557
+7% +$69.9K ﹤0.01% 1984
2015
Q1 		$1.05M Sell
21,382
-7,913
-27% -$367K ﹤0.01% 1767
2014
Q4 		$1.33M Buy
+29,295
New +$1.15M ﹤0.01% 1724

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Allianz Asset Management's AVNS Position: Q2 2026 in Review

Allianz Asset Management increased its Avanos Medical (AVNS) stake by 41% in Q2 2026, buying an estimated $2.52M and bringing the position to 373,397 shares worth $9.29M. The position accounts for 0.01% of the portfolio, ranked #1108.

Allianz Asset Management first reported a position in AVNS in Q4 2014 and has held it in 25 quarters since. The position peaked at $21.5M in Q2 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Allianz Asset Management held 373,397 shares of Avanos Medical worth $9.29M as of Q2 2026.
  • Allianz Asset Management bought 107,825 Avanos Medical shares in Q2 2026, an estimated $2.52M.
  • Avanos Medical made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1108 holding.
  • Allianz Asset Management first reported a position in Avanos Medical in Q4 2014 and has held it in 25 quarters since.
  • Allianz Asset Management's Avanos Medical position peaked at $21.5M in Q2 2018.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.